- Home
- SYPR vs DXR Comparison
SYPR vs DXR Comparison
Compare SYPR & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYPR
- DXR
- Stock Information
- Founded
- SYPR 1997
- DXR 1970
- Country
- SYPR United States
- DXR United States
- Employees
- SYPR N/A
- DXR N/A
- Industry
- SYPR Industrial Machinery/Components
- DXR Medical/Dental Instruments
- Sector
- SYPR Industrials
- DXR Health Care
- Exchange
- SYPR Nasdaq
- DXR Nasdaq
- Market Cap
- SYPR 36.8M
- DXR 36.4M
- IPO Year
- SYPR 1994
- DXR N/A
- Fundamental
- Price
- SYPR $1.62
- DXR $7.75
- Analyst Decision
- SYPR
- DXR Strong Buy
- Analyst Count
- SYPR 0
- DXR 1
- Target Price
- SYPR N/A
- DXR $25.00
- AVG Volume (30 Days)
- SYPR 14.6K
- DXR 4.9K
- Earning Date
- SYPR 05-23-2025
- DXR 01-01-0001
- Dividend Yield
- SYPR N/A
- DXR N/A
- EPS Growth
- SYPR N/A
- DXR 86.16
- EPS
- SYPR N/A
- DXR 0.11
- Revenue
- SYPR $140,180,000.00
- DXR $119,714.00
- Revenue This Year
- SYPR N/A
- DXR N/A
- Revenue Next Year
- SYPR N/A
- DXR N/A
- P/E Ratio
- SYPR N/A
- DXR $71.30
- Revenue Growth
- SYPR 2.90
- DXR N/A
- 52 Week Low
- SYPR $1.30
- DXR $6.55
- 52 Week High
- SYPR $3.72
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- SYPR 46.71
- DXR 51.69
- Support Level
- SYPR $1.58
- DXR $7.13
- Resistance Level
- SYPR $1.68
- DXR $7.74
- Average True Range (ATR)
- SYPR 0.07
- DXR 0.33
- MACD
- SYPR -0.00
- DXR 0.02
- Stochastic Oscillator
- SYPR 41.18
- DXR 89.04
About SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.